Methods of treatment with taselisib
- 专利权人:
- F. Hoffmann-La Roche AG
- 发明人:
- Edgar, Kyle,Friedman, Lori,Sampath, Deepak,Song, Kyung,Wertz, Ingrid,Wilson, Timothy
- 申请号：
- AU2016287189
- 公开号：
- AU2016287189A1
- 申请日:
- 2016.06.28
- 申请国别(地区):
- AU
- 年份:
- 2017
- 代理人:
- 摘要：
- Taselisib (GDC-0032) induces the degradation of mutant-p110 alpha protein. Methods for selecting patients with mutant PI3K tumors for treatment with taselisib are described.
- 来源网站：
- 中国工程科技知识中心
